: Multiple Sclerosis (MS) is a chronic neurological disease of the central nervous system characterized by multifocal inflammation, demyelination and axonal damage. The disease process shows inflammation resulting in multiple patches of demyelination in MRI analyses of CNS. MS shows a high-degree of individual variability in the severity and progress of the disease. The diagnosis of MS is still mainly based on the characteristic clinical symptoms. There are no specific laboratory tests for MS. However, changes in MRI and presence of oligoclonal IgG bands in the cerebrospinal fluid are used as supporting findings for the clinical diagnosis. In spite of extensive research, the basic molecular events in the initiation and progression of MS are still poorly understood. Most MS cases are sporadic, but family twin and adoption studies indicate a strong genetic component in the pathogenesis of the disease. As in most complex diseases, the genetic contribution, although important, is by no means the sole determinant, but environmental, so far unidentified, factors contribute to the pathogenesis. Due to the evident genetic contribution in MS, we hypothesize that distinct allelic variations predispose to MS. We further hypothesize that well-characterized, ethnically-homogenous populations provide advantages in identification of genetic variations predisposing to complex traits, such as MS. Thus, we aim to identify gene variants predisposing to MS. We will focus on genetic loci, which we have previously identified in a genome-wide scan and now restricted to a few megabases. Our strategy is to utilize the unique, ethnically homogenous population sample of Finnish MS families. More specifically, we aim to: 1) Restrict chromosomal loci linked to MS by monitoring for association and linkage disequilibrium, in MS alleles using multiple single nucleotide polymorphisms in the critical regions on chromosomes-5 and -17; 2) monitor differential expression of genes located on the critical region of Chr.-5 and -17 using expression microarrays; and 3) sequence candidate genes selected in Aims 1 and 2 to detect allelic variants contributing to MS, and test these allelic variants in a study sample from more heterogeneous populations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS043559-02
Application #
6665076
Study Section
Special Emphasis Panel (ZNS1-SRB-S (01))
Program Officer
Utz, Ursula
Project Start
2002-09-30
Project End
2006-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
2
Fiscal Year
2003
Total Cost
$253,531
Indirect Cost
Name
University of California Los Angeles
Department
Genetics
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
International Multiple Sclerosis Genetics Consortium (2011) The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study. PLoS One 6:e18813
International Multiple Sclerosis Genetics Consortium (see original citation for additional authors) (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214-9
Jakkula, Eveliina; Leppä, Virpi; Sulonen, Anna-Maija et al. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 86:285-91
De Jager, Philip L; Baecher-Allan, Clare; Maier, Lisa M et al. (2009) The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A 106:5264-9
Kallio, Suvi P; Jakkula, Eveliina; Purcell, Shaun et al. (2009) Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS. Hum Mol Genet 18:1670-83
Kemppinen, Anu; Suvela, Minna; Tienari, Pentti J et al. (2009) MYO9B polymorphisms in multiple sclerosis. Eur J Hum Genet 17:840-3
Sulonen, Anna-Maija; Kallio, Suvi P; Ellonen, Pekka et al. (2009) No evidence for shared etiology in two demyelinative disorders, MS and PLOSL. J Neuroimmunol 206:86-90
International Multiple Sclerosis Genetics Consortium (IMSGC) (2008) Refining genetic associations in multiple sclerosis. Lancet Neurol 7:567-9
Li, Ker-Chau; Palotie, Aarno; Yuan, Shinsheng et al. (2007) Finding disease candidate genes by liquid association. Genome Biol 8:R205
Kiialainen, Anna; Veckman, Ville; Saharinen, Juha et al. (2007) Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response. J Mol Med 85:971-83

Showing the most recent 10 out of 17 publications